NASDAQ: LSTA - Lisata Therapeutics, Inc.

半年間の収益性: -21.67%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Lisata Therapeutics, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases.

さらに詳しく
Its product candidates include LSTA1, which is in Phase 1b/2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; HONEDRA, a recipient of SAKIGAKE designation critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and LSTA201, a CD34+ cell therapy for the treatment of chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 1999-03-01
ISIN US1280583022
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.lisata.com
Цена ао 2.43
1日あたりの価格変動: -2.51% (2.4104)
週ごとの価格変動: -1.26% (2.38)
月ごとの料金変更: -1.67% (2.39)
3ヶ月間の価格変動: -22.19% (3.0201)
半年間の価格変動: -21.67% (3)
年間の価格変動: -24.68% (3.12)
3年間の価格推移: +201.28% (0.78)
5年間の価格推移: -0.4237% (2.36)
年初からの価格変動: -22.19% (3.02)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0.1067 10
P/BV 0.477 10
P/E 0 0
EV/EBITDA -0.0219 0
合計: 6.25

効率

名前 意味 学年
ROA, % -38.1 0
ROE, % -43.28 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.012 10
合計: 9.8

成長の衝動

名前 意味 学年
収益性 Revenue, % 727.43 10
収益性 Ebitda, % 32.22 5
収益性 EPS, % -91.16 0
合計: 3.4
さらに詳しく

機関 音量 共有, %
Bml Capital Management, LLC 269839 3.25
Vanguard Group Inc 176965 2.13
Renaissance Technologies, LLC 97222 1.17
Blackrock Inc. 56250 0.68
Geode Capital Management, LLC 43390 0.52
Susquehanna International Group, LLP 33749 0.41
State Street Corporation 14348 0.17
Citadel Advisors Llc 14131 0.17
Cook Wealth Management Group LLC 12175 0.15
HighTower Advisors, LLC 10044 0.12



スーパーバイザー 役職 支払い 生年
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D. President, CEO & Director 1.16M 1957 (68 年)
Dr. Kristen K. Buck M.D. Executive VP of R&D and Chief Medical Officer 938.42k 1974 (51 年)
Mr. James Nisco Senior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer N/A 1971 (54 年)
Mr. Tariq Imam Vice President of Business Development & Operations and Corporate Counsel N/A
Mr. Gregory S. Berkin Chief Information Officer N/A
Mr. John D. Menditto Vice President of Investor Relations & Corporate Communications N/A
Ms. Gail Holler Vice President of Human Resources N/A 1959 (66 年)
Dr. William K. Sietsema Ph.D. Vice President of Global Regulatory Affairs 350.55k 1956 (69 年)

住所: United States, Basking Ridge. NJ, 110 Allen Road - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.lisata.com